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licenseAre hepatitis B carriers more vulnerable to exercise-related liver
injury? Recent evidence from a 7-day ultramarathon1. The impact of exercise on liver enzyme tests
Alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) are the most well-known liver enzyme tests
used to diagnose hepatocyte injury. Besides, these two
enzymes are localized in the liver at high concentrations. AST
is also present in the heart, skeletal muscle, kidneys, pancreas,
brain, and red blood cells in considerable amounts. However,
ALT is present in low concentrations in skeletal muscle and
other extrahepatic organs. Therefore, ALT is an indicator of
liver damage in most situations, and AST is a less specific
marker of liver injury. The presence of these enzymes in the
blood is due to changes in membrane permeability as well as
cellular disruption, damage, and death. These enzymes are
also observed in blood in response to exercise.
Many previous studies have revealed that endurance exer-
cise, especially marathon race, may increase the serum level of
ALT, AST, bilirubin, alkaline phosphatase (ALP), lactate
dehydrogenase, and creatine kinase, and decrease serum
albumin and protein.1e6
During aerobic energy production, aminotransferases can
catabolize amino acids, allowing them to enter the citric acid
cycle, and thus generating adenosine triphosphate to maintain
muscle contraction and substantial physiologic response, such
as increased heart and respiratory rates and thermoregulation.
It is generally believed that the elevation of ALT and AST
levels after exercise originates mainly from muscle, and that
only small amounts originate from the liver.1e3
The increase in bilirubin may be caused by foot-strike
intravascular hemolysis, intramuscular destruction of red
blood cells due to osmotic stress, and membrane lipid perox-
idation caused by free radicals released by activated white
cells.6
ALP is an enzyme that can transport metabolites across cell
membranes including lipids for oxidative energy production.
Liver and bone diseases are the most common causes of
pathological elevation of ALP, followed by intestinal prob-
lems. The origin of exercise-related elevation of ALP was
believed to arise mainly from osteoblasts in the bone by the
stress and stimulation from exercise, although little data
regarding the isoenzyme of ALP have been reported in thex.doi.org/10.1016/j.jcma.2015.12.003
901/Copyright © 2016, the Chinese Medical Association. Published by El
(http://creativecommons.org/licenses/by-nc-nd/4.0/).literature.6 The rise in ALP level may also reflect that liver
increases gluconeogenesis and lipid peroxidation activity, and
high bone turnover induced by exercise. However, release of
ALP from the hepatobiliary system after exercise may play
only a minor role in the elevation of serum ALP level.
Albumin is mainly synthesized in the liver, and serum
albumin level is regarded as an indicator of liver function
representing liver reserve. Decreased serum albumin level
after exercise was observed in some studies, which may reflect
damage to the anabolic functioning of hepatic cells or the
long-term fasting after the marathon. Decreased total protein
after exercise was also shown in some reports, which may be
merely due to the reduction of serum albumin.6
2. Detrimental effect of chronic hepatitis B infection on
liver enzyme test in marathon runners
In this issue of the Journal of the Chinese Medical Asso-
ciation, Chou et al7 intended to investigate the impact of
hepatitis B virus (HBV) carrier status on the aforementioned
liver enzyme tests during multiday marathon races. This pro-
spective study recruited 10 Taiwanese runners participating in
7-day ultramarathon races, including three HBV carriers. The
authors found that there were higher serum ALT, AST, and
total bilirubin levels in the HBV carriers compared with the
noncarriers, and the time-by-group interaction was also sig-
nificant for these biomarkers. There were no significant time-
by-group effects on the serum ALP, albumin, and total protein
levels, but the change over time effect was significant. They
concluded that liver functions in HBV carriers are more highly
impacted by the 7-day marathon than those in noncarriers.
This is the first paper to disclose the potential for liver injury
after extended duration marathon running in HBV carriers.
Most of the previous studies suggest that elevated levels of
serum transferases and other enzymes after endurance exercise
mostly originate from muscle, instead of the liver.1e3,6 How-
ever, this study highlights the possibility of a hepatic origin of
the enzymes, owing to the higher levels of these enzymes in
HBV carriers compared with noncarriers.
The same study group has published a relevant paper
concerning the influence of a 100-km marathon on HBVsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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found no statistical difference in all biomarkers of liver,
muscle, and inflammation between HBV carriers and non-
carriers. They suggest that HBV carriers do not have higher
risks of liver function impairment, muscle breakdown, and
inflammatory response compared with noncarriers in the 100-
km endurance race.
The different results between these two studies suggest that
the duration of exercise may be the key determinant of hepatic
damage in HBV carriers.7,8 It is unfortunate that there was no
direct comparison of data between the 1- and 7-day marathons.
The further limitations of the present study are the very limited
number of cases and controls, and the absence of data
regarding HBV DNA before and after the race. However, the
overall number of runners participating in the ultramarathons,
especially 7-day races, is extremely low worldwide. However,
there were sequential data between HBV carriers and non-
carriers during the race in the present study. Therefore, this
study is still of value to enhance our understanding of the
impact of multiday marathon on the liver function of HBV
carriers. However, a prospective study utilizing a larger sample
size should be conducted to more reliably reach further
conclusions.
3. The mechanism of liver injury by acute exercise
Little is known about how exercise affects the liver during
acute exercise. Evidence has shown that arterial inflow sup-
plying the liver is decreased during acute exercise.9,10 In fact,
the blood flow can be reduced to as low as 20% of its resting
value.9 It is possible that hypoperfusion of the liver may insult
the hepatocytes and thus release liver enzymes into circu-
lation. Furthermore, epithelial integrity and gut wall barrier
function might also be compromised with repeated exposure to
strenuous physical stress, which is the other explanation
regarding release of the associated enzymes into blood.
However, evidence provided in the relevant study regarding
this point is scant, and the real mechanism is yet to be
elucidated.
4. Summary
Exercise, especially participation in a marathon race, may
induce elevation of many serum enzymes, representing insult
to muscle, liver, or heart. It is generally believed that the
increases of these enzymes after exercise are mainly from
muscle. In this issue of the Journal of the Chinese Medical
Association, a study from Taiwan found that that there were
higher serum ALT, AST, and total bilirubin levels in the HBV
carriers compared with the noncarriers in a 7-day ultra-
marathon race. This result implicates that the liver also con-
tributes to the elevation of these enzymes after exercise, andthat HBV carriers may be more vulnerable to hepatic damage
by multiday marathon. Although this finding warrants further
large-scale prospective studies to provide additional support,
physicians and HBV carriers should be aware of the potential
hepatic damage from such acute vigorous exercise.Conflicts of interest
The author declares that he has no conflicts of interest
related to the subject matter or materials discussed in this
article.References
1. Wu HJ, Chen KT, Shee BW, Chang HC, Huang YJ, Yang RS. Effects of
24 h ultra-marathon on biochemical and hematological parameters. World
J Gastroenterol 2004;10:2711e4.
2. Smith J, Garbutt G, Lopes P, Pedoe DT. Effects of prolonged strenuous
exercise (marathon running) on biochemical and haematological markers
used in the investigation of patients in the emergency department. Br J
Sports Med 2004;38:292e4.
3. Pettersson J, Hindorf U, Persson P, Bengtsson T, Malmqvist U,
Werkstr€om V, et al. Muscular exercise can cause highly pathological liver
function tests in healthy men. Br J Clin Pharmacol 2007;65:253e9.
4. Lippi G, Schena F, Montagnana M, Salvagno GL, Banfi G, Guidi GC.
Significant variation of traditional markers of liver injury after a half-
marathon run. Eur J Intern Med 2011;22:e36e8.
5. Nie J, Tong TK, George K, Fu FH, Lin H, Shi Q. Resting and post-
exercise serum biomarkers of cardiac and skeletal muscle damage in
adolescent runners. Scand J Med Sci Sports 2011;21:625e9.
6. Banfi G, Colombini A, Lombardi G, Lubkowska A. Metabolic markers in
sports medicine. Adv Clin Chem 2012;56:1e54.
7. Chou SL, Chou MY, Wang YS, Kuo FC, Kao WF. The impact of chronic
carrier of hepatitis B virus on liver function in a 7-day ultramarathon race.
J Chin Med Assoc 2016;79:179e84.
8. Chiu YH, Hou SK, How CK, Li LH, Kao WF, Yang CC, et al. Influence of
a 100-km ultra-marathon on hepatitis B carrier runners. Int J Sports Med
2013;34:841e5.
9. Heinonen I, Kalliokoski KK, Hannukainen JC, Duncker DJ, Nuutila P,
Knuuti J. Organ-specific physiological responses to acute physical exer-
cise and long-term training in humans. Physiology (Bethesda)
2014;29:421e36.
10. Shephard RJ, Johnson N. Effects of physical activity upon the liver. Eur J
Appl Physiol 2015;115:1e46.
Yi-Shin Huang*
Division of Gastroenterology and Hepatology, Department of
Medicine, Taipei Veterans General Hospital and National
Yang-Ming University School of Medicine, Taipei,
Taiwan, ROC
*Corresponding author. Dr. Yi-Shin Huang, Division of Gas-
troenterology and Hepatology, Department of Medicine,
Taipei Veterans General Hospital, 201, Section 2, Shih-Pai
Road, Taipei 112, Taiwan, ROC.
E-mail address: yshuang@vghtpe.gov.tw.
